{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:04:27Z","timestamp":1789049067265,"version":"build-2803163510"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017683","name":"Frederick A. DeLuca Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017683","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Antiphospholipid syndrome (APS) is an autoimmune disease with thromboembolic and obstetric morbidity arising via a model of immunothrombosis. Individuals with APS may present with thrombotic (TAPS), obstetric (OAPS), or microvascular (MAPS) disease, while many have circulating antiphospholipid antibodies (aPL) without APS classification (NoAPS). Multiple pathophysiologic mechanisms have been proposed in APS, including activation by aPL of platelets, endothelial and immune cells, as well as complement and coagulation pathways; however, the pathophysiology of APS, particularly transition of clinical APS from aPL remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Seeking to define the inflammatory signature of APS, we carried out an unbiased proteomic screen of persistently aPL-positive patients with different clinical phenotypes from the international APS Alliance for Clinical Trials and International Networking (ACTION) Registry and compared them to 10 healthy controls. 6398 unique proteins were estimated using an DNA aptamer-based assay. Subsequently, we validated our findings in 34 additional patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our data show that the mere presence of aPL confers a distinct thromboinflammatory signature characterized by the activation of coagulation, complement, innate and adaptive immune response pathways shared by all APS subtypes. Pathway enrichment analysis revealed increasing enrichment with rising statistical significance of thrombosis, complement, neutrophil and other innate and adaptive immune activation, as well as extracellular matrix (ECM) organization with increasing clinical severity, suggesting a model of progressive thromboinflammation in evolution of APS from NoAPS to TAPS and MAPS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings provide novel insights into the pathogenesis of APS and identify potential novel targets for diagnostic and therapeutic intervention in APS across its entire spectrum.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1676578","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T05:32:53Z","timestamp":1760592773000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry"],"prefix":"10.3389","volume":"16","author":[{"given":"Alexander","family":"Pine","sequence":"first","affiliation":[{"name":"Section of Hematology, Yale University School of Medicine","place":["New Haven, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Butt","sequence":"additional","affiliation":[{"name":"Section of Hematology, Yale University School of Medicine","place":["New Haven, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Andreoli","sequence":"additional","affiliation":[{"name":"University of Brescia","place":["Brescia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"Knight","sequence":"additional","affiliation":[{"name":"University of Michigan","place":["Ann Arbor, MI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gerosa","sequence":"additional","affiliation":[{"name":"University of Milan","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cecchi","sequence":"additional","affiliation":[{"name":"University of Turin","place":["Turin, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Ware","family":"Branch","sequence":"additional","affiliation":[{"name":"University of Utah and Intermountain Healthcare","place":["Salt Lake, UT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Lopez-Pedrera","sequence":"additional","affiliation":[{"name":"Maimonides Institute of Biomedical Research of Cordoba","place":["C\u00f3rdoba, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Michael","family":"Belmont","sequence":"additional","affiliation":[{"name":"New York University Langone Medical Center","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Kello","sequence":"additional","affiliation":[{"name":"Northwell Health","place":["New Hyde Park, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Petri","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine","place":["Baltimore, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[{"name":"Department of Autoimmune Diseases, Hospital Cl\u00ednic, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), University of Barcelona","place":["Barcelona, Catalonia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Pengo","sequence":"additional","affiliation":[{"name":"University of Padova","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Meroni","sequence":"additional","affiliation":[{"name":"IRCCS Istituto Auxologico Italiano","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Cohen","sequence":"additional","affiliation":[{"name":"University College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Willis","sequence":"additional","affiliation":[{"name":"University of Texas Medical","place":["Galveston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Bertolaccini","sequence":"additional","affiliation":[{"name":"St Thomas\u2019 Hospital","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Goshua","sequence":"additional","affiliation":[{"name":"Section of Hematology, Yale University School of Medicine","place":["New Haven, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Gu","sequence":"additional","affiliation":[{"name":"Yale Cardiovascular Research Center, Yale University School of Medicine","place":["New Haven, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hwa","sequence":"additional","affiliation":[{"name":"Yale Cardiovascular Research Center, Yale University School of Medicine","place":["New Haven, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred I.","family":"Lee","sequence":"additional","affiliation":[{"name":"Section of Hematology, Yale University School of Medicine","place":["New Haven, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doruk","family":"Erkan","sequence":"additional","affiliation":[{"name":"Hospital for Special Surgery and Weill Cornell Medicine","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish V.","family":"Sharda","sequence":"additional","affiliation":[{"name":"Section of Hematology, Yale University School of Medicine","place":["New Haven, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"379","author":"Garcia","year":"2018","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"18005","DOI":"10.1038\/nrdp.2018.5","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069717","article-title":"Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management","volume":"380","author":"Knight","year":"2023","journal-title":"BMJ"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00969","article-title":"Cellular and molecular mechanisms of anti-phospholipid syndrome","volume":"9","author":"Radic","year":"2018","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91374-J","article-title":"Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor","volume":"335","author":"Galli","year":"1990","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-300715","article-title":"beta(2)-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model","volume":"117","author":"Arad","year":"2011","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.188","article-title":"Screening: Guidelines for antiphospholipid antibody detection","volume":"8","author":"de Groot","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.683803","article-title":"NLRP3 inflammasome assembly in neutrophils is supported by PAD4 and promotes NETosis under sterile conditions","volume":"12","author":"Munzer","year":"2021","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1155222","article-title":"Pyroptosis-triggered pathogenesis: New insights on antiphospholipid syndrome","volume":"14","author":"Tan","year":"2023","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1160\/TH12-03-0212","article-title":"Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome","volume":"109","author":"Bontadi","year":"2013","journal-title":"Thromb Haemost"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314536479","article-title":"Toll-like receptor 4 and beta2 glycoprotein I interaction on endothelial cells","volume":"23","author":"Borghi","year":"2014","journal-title":"Lupus"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12536","article-title":"NF-kappaB is activated from endosomal compartments in antiphospholipid antibodies-treated human monocytes","volume":"12","author":"Brandt","year":"2014","journal-title":"J Thromb Haemost"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-378851","article-title":"Autoantibodies specific to a peptide of beta2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes","volume":"120","author":"Colasanti","year":"2012","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.1038\/s41467-023-41159-z","article-title":"Comprehensive proteomics and meta-analysis of COVID-19 host response","volume":"14","author":"Babacic","year":"2023","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"100287","DOI":"10.1016\/j.xcrm.2021.100287","article-title":"Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions","volume":"2","author":"Filbin","year":"2021","journal-title":"Cell Rep Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-023-00775-1","article-title":"A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures","volume":"5","author":"Govaere","year":"2023","journal-title":"Nat Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf5681","article-title":"Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life","volume":"15","author":"Walker","year":"2023","journal-title":"Sci Transl Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24468","article-title":"Characteristics of patients with antiphospholipid antibody positivity in the APS ACTION international clinical database and repository","volume":"74","author":"Sevim","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.49","article-title":"Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents","volume":"3","author":"Rohloff","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06563-x","article-title":"Large-scale plasma proteomics comparisons through genetics and disease associations","volume":"622","author":"Eldjarn","year":"2023","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaf030","article-title":"Correlations within and between highly multiplexed proteomic assays of human plasma","author":"Rooney","year":"2025","journal-title":"Clin Chem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1101\/2025.02.14.638375","article-title":"The current landscape of plasma proteomics: technical advances, biological insights, and biomarker discovery","volume":"8","author":"Kirsher","year":"2025","journal-title":"bioRxiv"},{"key":"B25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinf"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0351-2","article-title":"Immunological adaptations in pregnancy that modulate rheumatoid arthritis disease activity","volume":"16","author":"Forger","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12948-016-0048-x","article-title":"How pregnancy can affect autoimmune diseases progression","volume":"14","author":"Piccinni","year":"2016","journal-title":"Clin Mol Allergy"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-340232","article-title":"Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study","volume":"118","author":"Pengo","year":"2011","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2021.1948998","article-title":"Drug discovery strategies for novel leukotriene A4 hydrolase inhibitors","volume":"16","author":"Rohn","year":"2021","journal-title":"Expert Opin Drug Discov"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052371","article-title":"Neutrophil-derived leukotriene B4 is required for inflammatory arthritis","volume":"203","author":"Chen","year":"2006","journal-title":"J Exp Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00358","article-title":"NAMPT and NAPRT: two metabolic enzymes with key roles in inflammation","volume":"10","author":"Audrito","year":"2020","journal-title":"Front Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ymthe.2022.09.013","article-title":"NAMPT is a metabolic checkpoint of IFNgamma-producing CD4(+) T cells in lupus nephritis","volume":"31","author":"Li","year":"2023","journal-title":"Mol Ther"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00449","article-title":"Complement in the pathophysiology of the antiphospholipid syndrome","volume":"10","author":"Chaturvedi","year":"2019","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.09.010","article-title":"Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry","volume":"15","author":"Rodriguez-Pinto","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a005132","article-title":"Extracellular matrix proteins in hemostasis and thrombosis","volume":"4","author":"Bergmeier","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nri2852","article-title":"The impact of the extracellular matrix on inflammation","volume":"10","author":"Sorokin","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"13957","DOI":"10.1038\/ncomms13957","article-title":"Death receptor 6 contributes to autoimmunity in lupus-prone mice","volume":"8","author":"Fujikura","year":"2017","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1002\/art.39247","article-title":"Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome","volume":"67","author":"Yalavarthi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.24437","article-title":"Diverse stimuli engage different neutrophil extracellular trap pathways","volume":"6","author":"Kenny","year":"2017","journal-title":"Elife"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"102978","DOI":"10.1016\/j.jaut.2022.102978","article-title":"Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome","volume":"134","author":"Verrou","year":"2023","journal-title":"J Autoimmun"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e93897","DOI":"10.1172\/jci.insight.93897","article-title":"Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target","volume":"2","author":"Knight","year":"2017","journal-title":"JCI Insight"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204600","article-title":"Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus","volume":"74","author":"Perez-Sanchez","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.11.004","article-title":"Enhanced type I interferon gene signature in primary antiphospholipid syndrome: Association with earlier disease onset and preeclampsia","volume":"18","author":"Ugolini-Lopes","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac466","article-title":"Antiphospholipid antibodies in patients with calcific aortic valve stenosis","volume":"62","author":"Plunde","year":"2023","journal-title":"Rheumatol (Oxford)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"100202","DOI":"10.1016\/j.jtauto.2023.100202","article-title":"Antiphospholipid antibodies induce proinflammatory and procoagulant pathways in endothelial cells","volume":"6","author":"Patsouras","year":"2023","journal-title":"J Transl Autoimmun"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3840","article-title":"The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets","volume":"16","author":"Sleeboom","year":"2024","journal-title":"Sci Transl Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.915784","article-title":"Systematic identification of key extracellular proteins as the potential biomarkers in lupus nephritis","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S0143-4004(97)80040-9","article-title":"Synthesis of beta2 glycoprotein 1 by the human placenta","volume":"18","author":"Chamley","year":"1997","journal-title":"Placenta"},{"key":"B51","article-title":"Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome","volume":"21","author":"La Rosa","year":"1994","journal-title":"J Rheumatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2004.02.014","article-title":"Beta-2 glycoprotein I and its role in antiphospholipid syndrome-lessons from knockout mice","volume":"112","author":"Miyakis","year":"2004","journal-title":"Clin Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01681","article-title":"Essential role of complement in pregnancy: from implantation to parturition and beyond","volume":"11","author":"Girardi","year":"2020","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-339564","article-title":"beta(2)-glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator","volume":"118","author":"Gropp","year":"2011","journal-title":"Blood"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015628","article-title":"Novel insights into the effects of interleukin 6 antagonism in non-ST-segment-elevation myocardial infarction employing the SOMAscan proteomics platform","volume":"9","author":"George","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B56","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3233\/JAD-220399","article-title":"Comparative analysis of alzheimer's disease cerebrospinal fluid biomarkers measurement by multiplex SOMAscan platform and immunoassay-based approach","volume":"89","author":"Timsina","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1076029620905338","DOI":"10.1177\/1076029620905338","article-title":"Proteins involved in the induction of procoagulant activity and autoimmune response in patients with primary antiphospholipid syndrome","volume":"26","author":"Araujo","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"B58","doi-asserted-by":"publisher","first-page":"102982","DOI":"10.1016\/j.autrev.2021.102982","article-title":"Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review","volume":"20","author":"Anunciacion-Llunell","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s42003-024-05789-3","article-title":"Deep proteomic analysis of obstetric antiphospholipid syndrome by DIA-MS of extracellular vesicle enriched fractions","volume":"7","author":"Tian","year":"2024","journal-title":"Commun Biol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.702425","article-title":"Urine proteomics differentiate primary thrombotic antiphospholipid syndrome from obstetric antiphospholipid syndrome","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.autrev.2014.03.002","article-title":"14th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome","volume":"13","author":"Cervera","year":"2014","journal-title":"Autoimmun Rev"}],"updated-by":[{"DOI":"10.3389\/fimmu.2026.1807468","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1676578\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T08:49:48Z","timestamp":1775810988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1676578\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2025.1676578"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1676578","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"article-number":"1676578"}}